MED. Pharm - Life Sciences bibliographies - in Harvard style

In-text: (Budd et al., 2003)

Your Bibliography: Budd, D., McDonald, J., Emsley, N., Cain, K. and Tobin, A., 2003. The C-terminal Tail of the M3-muscarinic Receptor Possesses Anti-apoptotic Properties. Journal of Biological Chemistry, 278(21), pp.19565-19573.

In-text: (Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Updated 2003 #, 2004)

Your Bibliography: COPD, 2004. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Updated 2003 #. 1(1), pp.105-141.

In-text: (Darby et al., 2015)

Your Bibliography: Darby, M., Schnoeller, C., Vira, A., Culley, F., Bobat, S., Logan, E., Kirstein, F., Wess, J., Cunningham, A., Brombacher, F., Selkirk, M. and Horsnell, W., 2015. The M3 Muscarinic Receptor Is Required for Optimal Adaptive Immunity to Helminth and Bacterial Infection. PLOS Pathogens, 11(1), p.e1004636.

In-text: (Harvey, Hussain and Maddock, 2014)

Your Bibliography: Harvey, K., Hussain, A. and Maddock, H., 2014. Ipratropium Bromide-Mediated Myocardial Injury in In Vitro Models of Myocardial Ischaemia/Reperfusion. Toxicological Sciences, 138(2), pp.457-467.

In-text: (Hossain et al., 2013)

Your Bibliography: Hossain, M., Ifuku, M., Take, S., Kawamura, J., Miake, K. and Katafuchi, T., 2013. Plasmalogens Rescue Neuronal Cell Death through an Activation of AKT and ERK Survival Signaling. PLoS ONE, 8(12), p.e83508.

In-text: (Miao et al., 2013)

Your Bibliography: Miao, Y., Zhou, J., Zhao, M., Liu, J., Sun, L., Yu, X., He, X., Pan, X. and Zang, W., 2013. Acetylcholine Attenuates Hypoxia/ Reoxygenation-Induced Mitochondrial and Cytosolic ROS Formation in H9c2 Cells via M2 Acetylcholine Receptor. Cellular Physiology and Biochemistry, 31(2-3), pp.189-198.

In-text: (Montuschi, Malerba, Santini and Miravitlles, 2014)

Your Bibliography: Montuschi, P., Malerba, M., Santini, G. and Miravitlles, M., 2014. Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping. Drug Discovery Today, 19(12), pp.1928-1935.

In-text: (Pan et al., 2012)

Your Bibliography: Pan, Z., Guo, Y., Qi, H., Fan, K., Wang, S., Zhao, H., Fan, Y., Xie, J., Guo, F., Hou, Y., Wang, N., Huo, R., Zhang, Y., Liu, Y. and Du, Z., 2012. M3 Subtype of Muscarinic Acetylcholine Receptor Promotes Cardioprotection via the Suppression of miR-376b-5p. PLoS ONE, 7(3), p.e32571.

In-text: (Rani et al., 2013)

Your Bibliography: Rani, N., Bharti, S., Manchanda, M., Nag, T., Ray, R., Chauhan, S., Kumari, S. and Arya, D., 2013. Regulation of Heat Shock Proteins 27 and 70, p-Akt/p-eNOS and MAPKs by Naringin Dampens Myocardial Injury and Dysfunction In Vivo after Ischemia/Reperfusion. PLoS ONE, 8(12), p.e82577.

In-text: (Roberts et al., 2013)

Your Bibliography: Roberts, M., Mapel, D., Bruse, S., Petersen, H. and Nyunoya, T., 2013. Development of a Modified BODE Index as a Mortality Risk Measure Among Older Adults With and Without Chronic Obstructive Pulmonary Disease. American Journal of Epidemiology, 178(7), pp.1150-1160.

In-text: (Roberts et al., 2013)

Your Bibliography: Roberts, M., Mapel, D., Bruse, S., Petersen, H. and Nyunoya, T., 2013. Development of a Modified BODE Index as a Mortality Risk Measure Among Older Adults With and Without Chronic Obstructive Pulmonary Disease. American Journal of Epidemiology, 178(7), pp.1150-1160.

In-text: (Roberts et al., 2013)

Your Bibliography: Roberts, M., Mapel, D., Bruse, S., Petersen, H. and Nyunoya, T., 2013. Development of a Modified BODE Index as a Mortality Risk Measure Among Older Adults With and Without Chronic Obstructive Pulmonary Disease. American Journal of Epidemiology, 178(7), pp.1150-1160.

In-text: (Shaik et al., 2012)

Your Bibliography: Shaik, N., Alhourani, E., Bosc, A., Liu, G., Towhid, S., Lupescu, A. and Lang, F., 2012. Stimulation of Suicidal Erythrocyte Death by Ipratropium Bromide. Cellular Physiology and Biochemistry, 30(6), pp.1517-1525.

In-text: (Simoens, 2013)

Your Bibliography: Simoens, S., 2013. Cost-effectiveness of pharmacotherapy for COPD in ambulatory care: a review. J Eval Clin Pract, 19(6), pp.1004-1011.

In-text: (Simoens, 2013)

Your Bibliography: Simoens, S., 2013. Cost-effectiveness of pharmacotherapy for COPD in ambulatory care: a review. J Eval Clin Pract, 19(6), pp.1004-1011.

In-text: (Singh, 2008)

Your Bibliography: Singh, S., 2008. Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease. JAMA, 300(12), p.1439.

In-text: (Slaughter, Stenger, Reagan and Jadcherla, 2014)

Your Bibliography: Slaughter, J., Stenger, M., Reagan, P. and Jadcherla, S., 2014. Inhaled bronchodilator use for infants with bronchopulmonary dysplasia. Journal of Perinatology, 35(1), pp.61-66.

In-text: (Soto-Campos et al., 2013)

Your Bibliography: Soto-Campos, J., Plaza, V., Soriano, J., Cabrera-López, C., Almonacid-Sánchez, C., Vazquez-Oliva, R., Serrano, J., Ballaz-Quincoces, A., Padilla-Galo, A. and Santos, V., 2013. “Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study”. BMC Pulm Med, 13(1), p.73.

In-text: (Soto-Campos et al., 2013)

Your Bibliography: Soto-Campos, J., Plaza, V., Soriano, J., Cabrera-López, C., Almonacid-Sánchez, C., Vazquez-Oliva, R., Serrano, J., Ballaz-Quincoces, A., Padilla-Galo, A. and Santos, V., 2013. “Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study”. BMC Pulm Med, 13(1), p.73.

In-text: (Yeves et al., 2014)

Your Bibliography: Yeves, A., Villa-Abrille, M., Pérez, N., Medina, A., Escudero, E. and Ennis, I., 2014. Physiological cardiac hypertrophy: Critical role of AKT in the prevention of NHE-1 hyperactivity. Journal of Molecular and Cellular Cardiology, 76, pp.186-195.

In-text: (Yue et al., 2006)

Your Bibliography: Yue, P., Zhang, Y., Du, Z., Xiao, J., Pan, Z., Wang, N., Yu, H., Ma, W., Qin, H., Wang, W., Lin, D. and Yang, B., 2006. Ischemia Impairs the Association Between Connexin 43 and M3 Subtype of Acetylcholine Muscarinic Receptor (M3-mAChR) in Ventricular Myocytes. Cellular Physiology and Biochemistry, 17(3-4), pp.129-136.